* Glaukos Corp GKOS.N reported a quarterly adjusted loss
of 52
cents per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of -55
cents. The mean expectation of thirteen analysts for the
quarter was for a loss of 51 cents per share. Wall Street
expected results to range from -58 cents to -45 cents per share.
* Revenue rose 19% to $95.69 million from a year ago;
analysts
expected $88.90 million.
* Glaukos Corp's reported EPS for the quarter was a loss of
$1.06.
* The company reported a quarterly loss of $53.87 million.
* Glaukos Corp shares had fallen by 0.4% this quarter and
gained 48.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 1% in
the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Glaukos Corp is
$120.00
This summary was machine generated from LSEG data July 31 at
09:00 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.51 -0.52 Missed
Mar. 31 2024 -0.57 -0.70 Missed
Dec. 31 2023 -0.55 -0.63 Missed
Sep. 30 2023 -0.55 -0.50 Beat